Last Call for Sopan Pharmaceuticals IPO: Subscription Closes Today

The public subscription period for Sopan Pharmaceuticals Limited’s Initial Public Offering (IPO) concludes today, April 21, 2026 (Baisakh 8). Following the successful allotment of shares to migrant workers, employees, and mutual funds, the company is now offering the remaining 34.74 lakh units to the general public. Investors can apply for a minimum of 10 units and a maximum of 11,000 units through the MeroShare portal or C-ASBA approved financial institutions. Managed by NMB Capital Limited, the IPO carries a CARE-NP Single B rating, indicating high risk. The company reports an internal rate of return (IRR) of 23.63%, with a projected payback period of approximately 8.11 years. Given that today is the deadline, investors are encouraged to submit their applications before the banking hours close to avoid technical delays.